09th week of 2022 patent applcation highlights part 11 |
Patent application number | Title | Published |
20220062207 | METHOD FOR MODULATING METABOLISM | 2022-03-03 |
20220062208 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | 2022-03-03 |
20220062209 | AGENT CONTAINING 4-PHENYLBUTYRATE, FOR PREVENTING OR TREATING PRESBYOPIA | 2022-03-03 |
20220062210 | TREATMENT OF VASCULOPATHY WITH PROSTACYCLIN AND MESENCHYMAL STEM CELLS | 2022-03-03 |
20220062211 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | 2022-03-03 |
20220062212 | Compositions and Methods for Treating Patients Suffering from Glioma or Leukemia | 2022-03-03 |
20220062213 | METHODS AND COMPOSITIONS OF SOLABEGRON FOR REDUCING BODY FAT | 2022-03-03 |
20220062214 | L-TRIIODOTHYRONINE (T3) FOR USE IN LIMITING MICROVASCULAR OBSTRUCTION | 2022-03-03 |
20220062215 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CIRCADIAN RHYTHM-RELATED DISORDERS, COMPRISING OXYIMINOMETHYLBENZENE DERIVATIVE AS ACTIVE INGREDIENT | 2022-03-03 |
20220062216 | COMPOSITIONS AND METHODS FOR INCREASING LEAN-TO-FAT MASS RATIO | 2022-03-03 |
20220062217 | PROPHYLAXIS AND MITIGATION OF MIGRAINE HEADACHES USING DIETARY PRECURSORS, PHOSPHOLIPIDS, MINERALS AND OTHER KETOGENIC SOURCES | 2022-03-03 |
20220062218 | COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2022-03-03 |
20220062219 | COMPOSITION AND METHOD FOR TREATING OR PROPHYLAXIS OF CORONAVIRUS AND CANCERS | 2022-03-03 |
20220062220 | PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING NEURODEGENERATIVE DISEASE | 2022-03-03 |
20220062221 | PAIN RELIEVING FORMULATIONS CONTAINING CANNABIS AND METHODS OF MAKING SAME | 2022-03-03 |
20220062222 | CROMOLYN ESTERS AND USES THEREOF | 2022-03-03 |
20220062223 | DIHYDROMYRICETIN SPRAY-DRIED DISPENSION FORMULATIONS AND METHODS FOR FORMING THEM | 2022-03-03 |
20220062224 | SUPPLEMENT THAT ENHANCES INTRACELLULAR CONCENTRATION OF BIOACTIVE MOLECULES THROUGH INHIBITION OF MULTIDRUG RESISTANT (MDR) EFFLUX PUMPS | 2022-03-03 |
20220062225 | METHODS FOR REDUCING NEGATIVE EFFECTS OF ALCOHOL CONSUMPTION | 2022-03-03 |
20220062226 | UROLITHIN A AND A COMPOSITION CONTAINING SAME FOR EXTERNAL USE IN INFLAMMATIONS OF VARIOUS ETIOLOGIES | 2022-03-03 |
20220062227 | ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS | 2022-03-03 |
20220062228 | USE OF CARNOSOL FOR INCREASING MUSCLE PROTEIN SYNTHESIS | 2022-03-03 |
20220062229 | METHODS OF TREATING SCHIZOPHRENIA | 2022-03-03 |
20220062230 | SUBSTITUTED BENZOTHIOPHENE ANALOGS AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS | 2022-03-03 |
20220062231 | TREATMENT FOR PRIMARY BILIARY CHOLANGITIS | 2022-03-03 |
20220062232 | Nitrile-Containing Antiviral Compounds | 2022-03-03 |
20220062233 | Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing Genes | 2022-03-03 |
20220062234 | NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF | 2022-03-03 |
20220062235 | METHODS AND MATERIALS FOR USING RUMINOCOCCUS GNAVUS OR CLOSTRIDIUM SPOROGENES TO TREAT GASTROINTESTINAL DISORDERS | 2022-03-03 |
20220062236 | PATCH | 2022-03-03 |
20220062237 | INJECTABLE FORMULATION | 2022-03-03 |
20220062238 | INJECTABLE FORMULATIONS | 2022-03-03 |
20220062239 | COMPOUNDS USEFUL AS KINASE INHIBITORS | 2022-03-03 |
20220062240 | METHODS OF TREATING CANCER USING A CLK INHIBITOR | 2022-03-03 |
20220062241 | METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | 2022-03-03 |
20220062242 | Methods and compositions for inhibiting mutant EGFR signaling | 2022-03-03 |
20220062243 | P14-Kinase Inhibitors with Anti-Cancer Activity | 2022-03-03 |
20220062244 | APPLICATION OF MONOCYCLIC -LACTAM COMPOUND IN PHARMACY | 2022-03-03 |
20220062245 | AGENT FOR IMPROVING INFERTILITY, RECURRENT MISCARRIAGE, AND STATE OF PREGNANCY | 2022-03-03 |
20220062246 | COMBINATION THERAPY FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER | 2022-03-03 |
20220062247 | USE OF A PAR-1 ANTAGONIST FOR THE TREATMENT OF A CHRONIC INFLAMMATORY INTESTINAL DISEASE | 2022-03-03 |
20220062248 | CEREBLON MODULATORS AND USES THEREOF | 2022-03-03 |
20220062249 | POWDER INJECTION OF THE DONEPEZIL SEMI PALMOXIRIC ACID SALT, COMPOSITION CONTAINING SAME AND PREPARATION METHOD THEREFOR | 2022-03-03 |
20220062250 | COMBINATION OF A SK2 INHIBITOR AND AN INHIBITOR OF A CHECKPOINT PATHWAY, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2022-03-03 |
20220062251 | New Topical Formulation for Use in Alopecia | 2022-03-03 |
20220062252 | CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES | 2022-03-03 |
20220062253 | Pantoprazole Compositions and Methods | 2022-03-03 |
20220062254 | INHIBITORS OF GANGLIOSIDES METABOLISM FOR THE TREATMENT OF MOTOR NEURON DISEASES | 2022-03-03 |
20220062255 | TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE | 2022-03-03 |
20220062256 | STABLE NIMODIPINE PARENTERAL FORMULATION | 2022-03-03 |
20220062257 | 5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION | 2022-03-03 |
20220062258 | Heterocyclic derivatives | 2022-03-03 |
20220062259 | TREATING AUTOIMMUNE DISEASE | 2022-03-03 |
20220062260 | COMBINATION THERAPY FOR TREATMENT OF LKB1 DEFICIENT CANCERS | 2022-03-03 |
20220062261 | Methods of Regulating Oxidoreductase Activity for Treatment of Inflammation and Age-Related Disorders | 2022-03-03 |
20220062262 | GSNO REDUCTASE INHIBITOR AS AN ADJUNCT THERAPY WITH REMOTE ISCHEMIC CONDITIONING AND THROMBOLYTIC REPERFUSION THERAPIES IN STROKE | 2022-03-03 |
20220062263 | CRYSTALLINE FORMS AND PROCESSES OF LENVATINIB BESYLATE | 2022-03-03 |
20220062264 | GSNO REDUCTASE INHIBITOR AS AN ADJUNCT THERAPY WITH REMOTE ISCHEMIC CONDITIONING AND THROMBOLYTIC REPERFUSION THERAPIES IN STROKE | 2022-03-03 |
20220062265 | DOSE REGIMENS FOR USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CNS DISORDERS | 2022-03-03 |
20220062266 | METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER | 2022-03-03 |
20220062267 | METHODS OF ACUTE RESTORATION OF VASCULAR COMPLIANCE | 2022-03-03 |
20220062268 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASE | 2022-03-03 |
20220062269 | MODULATORS OF AIRWAY BASAL CELLS FOR THE TREATMENT OR PREVENTION OF LUNG DISEASES | 2022-03-03 |
20220062270 | METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ACTIVATION OF INFLAMMASOMES | 2022-03-03 |
20220062271 | LOTEPREDNOL AND MOXIFLOXACIN COMPOSITIONS AND METHODS | 2022-03-03 |
20220062272 | QUINOLIN-2(1H)-ONE INHIBITORS OF LATE SV40 FACTOR | 2022-03-03 |
20220062273 | CONJUGATES OF PATTERN RECOGNITION RECEPTOR AGONISTS | 2022-03-03 |
20220062274 | NOVEL BRONCHODILATORS FOR TREATING OBSTRUCTIVE LUNG DISEASE | 2022-03-03 |
20220062275 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2022-03-03 |
20220062276 | PHARMACEUTICAL COMPOSITIONS | 2022-03-03 |
20220062277 | NALTREXONE INJECTABLE SUSTAINED RELEASE FORMULATION | 2022-03-03 |
20220062278 | SMALL MOLECULE INHIBITORS OF THE ANDROGEN RECEPTOR ACTIVITY AND/OR EXPRESSION AND USES THEREOF | 2022-03-03 |
20220062279 | TREATMENT OF MOVEMENT DISORDERS | 2022-03-03 |
20220062280 | SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR | 2022-03-03 |
20220062281 | INHIBITORS TO TARGET HIV-1 NEF-CD80/CD86 INTERACTIONS FOR THERAPEUTIC INTERVENTION | 2022-03-03 |
20220062282 | THERAPEUTIC DRUG FOR MOTOR COMPLICATIONS IN PARKINSON'S DISEASE | 2022-03-03 |
20220062283 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS | 2022-03-03 |
20220062284 | TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS | 2022-03-03 |
20220062285 | METHOD OF TREATING A SKIN DISORDER WITH EGFR INHIBITOR | 2022-03-03 |
20220062286 | USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER | 2022-03-03 |
20220062287 | PALATABLE FORMULATIONS | 2022-03-03 |
20220062288 | PHARMACEUTICAL COMPOSITIONS OF VIBEGRON FOR REDUCING BODY FAT | 2022-03-03 |
20220062289 | Nucleotide Analogs | 2022-03-03 |
20220062290 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | 2022-03-03 |
20220062291 | COMPOSITIONS AND METHODS OF TREATING CANCERS BY ADMINISTERING A PHENOTHIAZINE-RELATED DRUG THAT ACTIVATES PROTEIN PHOSPHATASE 2A (PP2A) WITH REDUCED INHIBITORY ACTIVITY TARGETED TO THE DOPAMINE D2 RECEPTOR AND ACCOMPANYING TOXICITY | 2022-03-03 |
20220062292 | APPLICATIONS FOR PROMETHAZINE IN PREPARING ANTI-LIVER CANCER AND/OR COLON CANCER AND/OR LUNG CANCER PRODUCTS | 2022-03-03 |
20220062293 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | 2022-03-03 |
20220062294 | PHARMACEUTICAL COMPOSITIONS OF TETRACYCLIC QUINOLONE ANALOGS AND THEIR SALTS | 2022-03-03 |
20220062295 | SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST | 2022-03-03 |
20220062296 | COMBINATIONS OF GABAA ALPHA 5 AGONISTS AND SV2A INHIBITORS AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT | 2022-03-03 |
20220062297 | USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS IN COMBINATION WITH GLUCOCORTICOIDS TO TREAT ADRENAL INSUFFICIENCY | 2022-03-03 |
20220062298 | ANTI-INFLAMMATORY COMPOSITION AND METHOD OF TREATMENT | 2022-03-03 |
20220062299 | USE OF GLUCOCORTICOID STEROIDS IN PREVENTING AND TREATING CONDITIONS OF MUSCLE WASTING, AGING AND METABOLIC DISORDER | 2022-03-03 |
20220062300 | SYNERGIC PHARMACEUTICAL COMPOSITION OF ACECLOFENAC AND BETAMETHASONE FOR TREATING THE PAIN OF RHEUMATIC CONDITIONS OR POSTSURGICAL PAIN | 2022-03-03 |
20220062301 | BROMFENAC, PREDNISOLONE, AND MOXIFLOXACIN COMPOSITIONS AND METHODS | 2022-03-03 |
20220062302 | GATIFLOXACIN, PREDNISOLONE, AND BROMFENAC COMPOSITIONS AND METHODS | 2022-03-03 |
20220062303 | PREDNISOLONE AND MOXIFLOXACIN COMPOSITIONS AND METHODS | 2022-03-03 |
20220062304 | Methods of vitamin D treatment | 2022-03-03 |
20220062305 | SUSTAINED RELEASE COMPOSITION COMPRISING AN ETHYLCELLULOSE | 2022-03-03 |
20220062306 | COMPOUNDS FOR PRENATAL TREATMENT COMPRISIING A NATAL VITAMIN AND ASPIRIN AND METHOD FOR MAKING AND USING THE SAME | 2022-03-03 |